Novartis Cough/Cold OTCs Boost Consumer Health Division In Q1
This article was originally published in The Tan Sheet
Executive Summary
Novartis' over-the-counter sales achieved double-digit growth in its first quarter on the strength of cough and cold brands and expansion into new markets, particularly Japan, the company said